Brighter Sheds Light on the Darkness of the Stock Markets

In the middle of one of the darkest periods on the stock markets, medtech company Brighter AB (publ) invites to its IPO at AktieTorget with the purpose to attract 8.5 MSEK. The executive board shines with stable optimism despite the darkness of the stock market. With the main patent approved one year earlier than planned, Brighter leaves the period as a pure development company and goes on to producing and commercializing the product portfolio Brighter One^TM, an attractive world news with great global potential.

”Through combining existing techniques, Brighter has achieved to attain a patent that lies as the base for an at the same time complex but also easy-to-use product for self-care of diabetes. The interest from the large companies that work with insulin production is already very big, which allows for good possibilities to reach a commercial breakthrough in a very short time” says Gert Westergren, chairman of the board of Brighter AB (publ).

Lars Flening, former head of Medisense Europe and present member of the board and partnership manager of Brighter, saw the growth potential immediately: ”Already at the first contact with the founders of Brighter, I realized that they had achieved to combine two different technologies that make it possible to ease life for diabetics all over the world, at the same time as they, in an early stage, had generated a great interest for Brighter One with the diabetes companies, future partners and buyers. When the founders then achieved to attain a patent protection a year earlier than any of us had hoped, we understood that it was time to take the company to a commercial phase”.

The CEO of the company, Truls Sjöstedt, is also very optimistic regarding the present situation: “Although the view on the financial markets right now is dark, to say the least, we have chosen to go to the market and seek capital. We make the assessment that our product, combined with the very strong patent we obtained during the spring 2011 and the potential that exists on the market, will attract both private and institutional investors. The interest is already great from both the diabetics themselves and among companies that work with diabetes related products.”

Michael Frantzén, founder and board member of Brighter, points out that recession has been to the company’s advantage in the past: “As we remember from past negotiations, Brighter has been able to buy, for example, consultancy services to significantly lower prices during recessions, for example once when we only by asking the question got a 100 000 SEK discount. In other words, 8.5 mkr should take us further during a recession than during a prosperous economic boom. So the situation doesn’t only imply challenges, but also good opportunities.”

Diabetes is one of the most common public health diseases in the Northic countries that, moreover, only continues to increase in the society. WHO estimates that we will have more than 150 million new diabetics in the world within the coming 20 years. The leadership of Brighter believes strongly that a large share of these will get easier lives in the future thanks to Brighter One ^TM and refers to the listing as a unique opportunity for the public to invest in Brighter and take part in this great growth opportunity.

Lars Flening - short background

Born 1948, with more than 30 years of experience from leading positions within the diagnostics and medtech industry, primarily as Head of Medisense Europe, pioneer within measuring of blood sugar with biosensor. Medisense was bought by Abbott Labs and became Abbott Diabetes Care, which is one of today's main players in the industry. Other positions include chairman of the diabetes group of Swedish Labtech and member of corresponding group within EDMA, European Diagnostics Manufacturers Association, and board member of Tynoxar AB.

About Brighter AB (publ)

Brighter develops and commercializes innovative solutions for diabetes self-cafe. It is a STING Alumni company. Financing has come from state and institutional investors such as ALMI, Innovationsbron, KAS Innovationsfond (an activity within the Karl-Adam Bonnier foundation) as well as from private investors.

During the period August 15 to September 2, there is a unique opportunity to issue shares in Brighter. After the introduction issuing, Brighter will be listed at AktieTorget. For more information: www.BrighterCompany.com.

Brighter's all-in-one solution: Brighter One TM Full Video

Contact Information

http://www.BrighterCompany.com/

http://www.BrighterCompany.com/video

http://www.facebook.com/brightercompany

http://twitter.com/Brighter_AB

Phone: +46 8 55 00 88 20

Fax: +46 8 55 00 88 30

Truls Sjöstedt, VD på Brighter AB (publ)

Phone: +46 709 73 46 00

E-mail: truls.sjostedt@brightercompany.com